UroAlert - GU Oncology Daily

May 28, 2026

Videos

Peer-to-Peer Clinical Conversations

Randomized Trial of Blue Light Versus White Light TURBT with Urinary Tumor DNA Testing - Armine Smith & Meghan McNamara

Armine Smith

Meghan McNamara and Armine Smith describe a randomized study combining blue-light TURBT with UroAmp urinary tumor DNA testing.

Phase 2 TheraPb Trial Evaluates a Novel Induction and Maintenance Regimen of 212Pb-ADVC001 Across Three Metastatic Prostate Cancer Indications - Anna Karmann

Anna Karmann

Anna Karmann outlines AdvanCell's Lead-212 alpha-emitting radioligand therapy program, covering the phase one experience and an emerging phase two design.

Beyond the Abstracts

CT-Based Renal Artery Caliber Change as a Potential Imaging Marker of Treatment Response in Renal Cell Carcinoma; an Exploratory Imaging Study - Beyond the Abstract

A Long Noncoding RNA-based Classifier for Identifying More Aggressive Low-grade Ta Bladder Cancer with Elevated FGFR3 Activity - Beyond the Abstract

Conference Coverage

AUA 2026: Role of Lymph Node Dissection at the Time of Radical Prostatectomy

AUA 2026: Development and Internal Validation of a Novel Prognostic Score for Real-world Renal Cell Carcinoma Patients Eligible for Adjuvant therapy

AUA 2026: Immune Microenvironment Signatures of Response to Cretostimogene Grenadenorepvec in BCG-Unresponsive Non–Muscle Invasive Bladder Cancer

AUA 2026: Cost Effectiveness Analysis of Sasanlimab + BCG for High-Risk NMIBC: Analysis From CREST

AUA 2026: ADVANCED-2 (Cohort A): Interim 12-Month Efficacy and Safety Data in BCG-Naïve Participants with High-Grade Non-Muscle Invasive Bladder Cancer

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

Trends in the diagnosis of variant bladder cancer: a national retrospective cohort analysis.

Proceedings of the first international NMIBC consensus classification meeting.

Penile & Urethral Cancers

Neoadjuvant Treatment for Penile Cancer: A Systematic Review of Contemporary Evidence.

Renal Cancer

Metastatic Patterns and Adverse Histopathologic Features in Advanced Renal Cell Carcinoma: A Five-Year Single-Center Retrospective Pathology Study.

Histologic Heterogeneity of Metastases in Clear Cell Renal Cell Carcinoma with Sarcomatoid Differentiation.

Prostate Cancer

PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer.

Emerging Therapeutic Strategies in Metastatic Hormone-Sensitive Prostate Cancer.

Analytical Validation of MyProstateScore 2.0-Active Surveillance: A Urinary-Based Clinical RT-PCR Prostate Cancer Assay.

Prioritising Data Quality Governance for AI in Prostate Cancer: A Methodological Proof-of-Concept Study Using Neural Networks for Risk Stratification.

Evaluating Oncological Outcomes in Patients with Multiple PiRADS Lesion Treated with Robot-Assisted Radical Prostatectomy for Prostate Cancer: Results from a Large Contemporary Cohort with Centralized MpMRI Evaluation in a High-Volume Center.

Upper Tract Tumors

Circulating Tumor DNA in Upper Tract Urothelial Carcinoma: A Framework for Precision Perioperative Management.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC